Bliss GVS Pharma Live BSE/NSE | Bliss GVS Pharma Fundamenta data | Bliss GVS Pharma Balance sheet | Bliss GVS Pharma Quarterly Results | Bliss GVS Pharma Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,072.22
30.05
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

2,089.86
0.25%
2.71

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.16
4.74
-5.42

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.69
-4.57
-8.97

PAT CAGR (%)

10 Years
5 Years
3 Years

9.12
3.35
18.28

P:E (Median)

8 Years
5 Years
3 Years

18.14
18.90
18.31

P:BV (Average)

8 Years
5 Years
3 Years

2.78
2.85
2.48

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.37
8.65
8.63

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 118.83 104.00 14.26% 114.02 115.16 -0.99% 97.97 106.14 -7.70% 124.82 95.63 30.52%
Expenses 92.25 82.55 11.75% 95.61 78.36 22.01% 84.99 92.21 -7.83% 95.89 70.99 35.08%
EBITDA 26.58 21.46 23.86% 18.40 36.80 -50.00% 12.98 13.94 -6.89% 28.93 24.64 17.41%
EBIDTM 22.37% 20.63% 16.14% 31.95% -0.29% 13.13% 23.18% 25.76%
Other Income 3.18 12.29 -74.13% 6.95 1.79 288.27% 15.24 3.02 404.64% 5.61 -4.35 -
Interest 0.03 0.76 -96.05% 1.52 0.61 149.18% 2.27 0.65 249.23% 0.92 0.68 35.29%
Depreciation 3.45 2.49 38.55% 3.43 1.87 83.42% 2.42 1.45 66.90% 2.06 1.34 53.73%
PBT 26.27 30.50 -13.87% 20.41 36.11 -43.48% 23.53 14.86 58.34% 31.56 18.27 72.74%
Tax 7.48 2.06 263.11% 3.31 12.19 -72.85% 7.11 10.22 -30.43% 8.01 6.57 21.92%
PAT 18.79 28.44 -33.93% 17.09 23.92 -28.55% 16.42 4.63 254.64% 23.56 11.70 101.37%
PATM 15.81% 27.34% 14.99% 20.77% 2.87% 4.37% 18.87% 12.24%
EPS 1.82 2.76 -34.06% 1.66 2.32 -28.45% 1.59 0.45 253.33% 2.28 1.13 101.77%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 151.54 210.12 -27.88% 129.55 211.53 -38.76% 119.80 244.37 -50.98% 147.85 220.44 -32.93%
Expenses 119.54 184.66 -35.26% 110.07 162.57 -32.29% 103.95 212.43 -51.07% 114.90 176.90 -35.05%
EBITDA 32.00 25.47 25.64% 19.48 48.96 -60.21% 15.85 31.94 -50.38% 32.95 43.54 -24.32%
EBIDTM 21.12% 12.12% 15.03% 23.15% 14.01% 13.07% 22.28% 19.75%
Other Income 2.74 12.90 -78.76% 7.04 2.11 233.65% 16.60 2.79 494.98% 5.52 -3.90 -
Interest 0.38 1.05 -63.81% 1.83 0.89 105.62% 2.39 0.93 156.99% 1.08 0.96 12.50%
Depreciation 4.31 3.50 23.14% 4.29 2.78 54.32% 3.34 2.20 51.82% 2.97 2.19 35.62%
PBT 30.05 33.81 -11.12% 20.40 47.40 -56.96% 13.33 31.60 -57.82% 34.41 36.48 -5.67%
Tax 8.44 2.95 186.10% 3.75 14.04 -73.29% 7.76 12.81 -39.42% 8.96 9.25 -3.14%
PAT 21.61 30.86 -29.97% 16.65 33.37 -50.10% 5.57 18.79 -70.36% 25.45 27.23 -6.54%
PATM 14.26% 14.69% 12.85% 15.77% 7.11% 7.69% 17.21% 12.35%
EPS 1.99 3.00 -33.67% 1.57 3.28 -52.13% 28.29 1.76 1,507.39% 2.30 2.50 -8.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 455.64 441.95 426.59 297.89 348.02 326.38 313.02 288.23 353.68 267.07 218.84 Net Sales Growth 8.25% 3.60% 43.20% -14.40% 6.63% 4.27% 8.60% -18.51% 32.43% 22.04% Cost Of Goods Sold 695.95 236.73 225.15 145.81 167.21 114.36 116.45 127.84 163.89 145.83 112.20 Gross Profit -240.31 205.23 201.44 152.08 180.80 212.03 196.57 160.40 189.79 121.24 106.65 GP Margin -52.74% 46.44% 47.22% 51.05% 51.95% 64.96% 62.80% 55.65% 53.66% 45.40% 48.73% Total Expenditure 368.74 341.78 333.49 209.43 247.49 229.87 226.83 222.16 252.90 195.55 160.11 Power & Fuel Cost - 4.70 3.57 2.59 2.73 2.82 2.69 1.80 1.45 1.01 0.54 % Of Sales - 1.06% 0.84% 0.87% 0.78% 0.86% 0.86% 0.62% 0.41% 0.38% 0.25% Employee Cost - 44.02 33.85 26.29 25.03 21.89 17.36 12.93 9.87 6.17 3.53 % Of Sales - 9.96% 7.94% 8.83% 7.19% 6.71% 5.55% 4.49% 2.79% 2.31% 1.61% Manufacturing Exp. - 5.20 4.24 3.64 3.31 23.87 27.77 20.26 24.04 12.66 15.88 % Of Sales - 1.18% 0.99% 1.22% 0.95% 7.31% 8.87% 7.03% 6.80% 4.74% 7.26% General & Admin Exp. - 10.05 13.71 11.11 11.73 17.31 18.20 10.21 10.52 7.31 5.21 % Of Sales - 2.27% 3.21% 3.73% 3.37% 5.30% 5.81% 3.54% 2.97% 2.74% 2.38% Selling & Distn. Exp. - 26.16 31.07 14.77 26.29 35.26 31.20 33.56 39.23 21.13 15.75 % Of Sales - 5.92% 7.28% 4.96% 7.55% 10.80% 9.97% 11.64% 11.09% 7.91% 7.20% Miscellaneous Exp. - 14.93 21.91 5.22 11.18 14.35 13.16 15.57 3.90 1.44 15.75 % Of Sales - 3.38% 5.14% 1.75% 3.21% 4.40% 4.20% 5.40% 1.10% 0.54% 3.20% EBITDA 86.89 100.17 93.10 88.46 100.53 96.51 86.19 66.07 100.78 71.52 58.73 EBITDA Margin 19.07% 22.67% 21.82% 29.70% 28.89% 29.57% 27.53% 22.92% 28.49% 26.78% 26.84% Other Income 30.98 34.93 35.81 10.99 9.08 23.08 21.35 30.12 15.03 15.86 1.87 Interest 4.74 4.56 3.15 6.95 9.07 13.53 11.21 9.44 6.55 4.02 2.15 Depreciation 11.36 8.83 5.75 5.67 5.62 5.85 5.08 4.46 4.43 3.65 5.47 PBT 101.77 121.71 120.01 86.84 94.91 100.21 91.25 82.30 104.83 79.71 52.98 Tax 25.91 29.38 45.58 29.82 35.77 34.60 31.24 28.37 48.15 26.88 12.35 Tax Rate 25.46% 24.14% 37.98% 34.34% 37.69% 34.53% 34.24% 34.47% 45.93% 33.72% 23.31% PAT 75.86 92.33 74.43 57.01 59.13 65.61 60.02 53.93 56.68 52.83 40.63 PAT before Minority Interest 75.86 92.33 74.43 57.01 59.13 65.61 60.02 53.93 56.68 52.83 40.63 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.65% 20.89% 17.45% 19.14% 16.99% 20.10% 19.17% 18.71% 16.03% 19.78% 18.57% PAT Growth 10.44% 24.05% 30.56% -3.59% -9.88% 9.31% 11.29% -4.85% 7.29% 30.03% Unadjusted EPS 7.36 8.96 7.22 5.53 5.74 6.36 5.82 5.23 5.50 5.12 3.94

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

455.64

441.95

426.59

297.89

348.02

326.38

313.02

288.23

353.68

267.07

218.84

Net Sales Growth

8.25%

3.60%

43.20%

-14.40%

6.63%

4.27%

8.60%

-18.51%

32.43%

22.04%

Cost Of Goods Sold

695.95

236.73

225.15

145.81

167.21

114.36

116.45

127.84

163.89

145.83

112.20

Gross Profit

-240.31

205.23

201.44

152.08

180.80

212.03

196.57

160.40

189.79

121.24

106.65

GP Margin

-52.74%

46.44%

47.22%

51.05%

51.95%

64.96%

62.80%

55.65%

53.66%

45.40%

48.73%

Total Expenditure

368.74

341.78

333.49

209.43

247.49

229.87

226.83

222.16

252.90

195.55

160.11

Power & Fuel Cost

4.70

3.57

2.59

2.73

2.82

2.69

1.80

1.45

1.01

0.54

% Of Sales

1.06%

0.84%

0.87%

0.78%

0.86%

0.62%

0.41%

0.38%

0.25%

Employee Cost

44.02

33.85

26.29

25.03

21.89

17.36

12.93

9.87

6.17

3.53

% Of Sales

9.96%

7.94%

8.83%

7.19%

6.71%

5.55%

4.49%

2.79%

2.31%

1.61%

Manufacturing Exp.

5.20

4.24

3.64

3.31

23.87

27.77

20.26

24.04

12.66

15.88

% Of Sales

1.18%

0.99%

1.22%

0.95%

7.31%

8.87%

7.03%

6.80%

4.74%

7.26%

General & Admin Exp.

10.05

13.71

11.11

11.73

17.31

18.20

10.21

10.52

7.31

5.21

% Of Sales

2.27%

3.21%

3.73%

3.37%

5.30%

5.81%

3.54%

2.97%

2.74%

2.38%

Selling & Distn. Exp.

26.16

31.07

14.77

26.29

35.26

31.20

33.56

39.23

21.13

15.75

% Of Sales

5.92%

7.28%

4.96%

7.55%

10.80%

9.97%

11.64%

11.09%

7.91%

7.20%

Miscellaneous Exp.

14.93

21.91

5.22

11.18

14.35

13.16

15.57

3.90

1.44

15.75

% Of Sales

3.38%

5.14%

1.75%

3.21%

4.40%

4.20%

5.40%

1.10%

0.54%

3.20%

EBITDA

86.89

100.17

93.10

88.46

100.53

96.51

86.19

66.07

100.78

71.52

58.73

EBITDA Margin

19.07%

22.67%

21.82%

29.70%

28.89%

29.57%

27.53%

22.92%

28.49%

26.78%

26.84%

Other Income

30.98

34.93

35.81

10.99

9.08

23.08

21.35

30.12

15.03

15.86

1.87

Interest

4.74

4.56

3.15

6.95

9.07

13.53

11.21

9.44

6.55

4.02

2.15

Depreciation

11.36

8.83

5.75

5.67

5.62

5.85

5.08

4.46

4.43

3.65

5.47

PBT

101.77

121.71

120.01

86.84

94.91

100.21

91.25

82.30

104.83

79.71

52.98

Tax

25.91

29.38

45.58

29.82

35.77

34.60

31.24

28.37

48.15

26.88

12.35

Tax Rate

25.46%

24.14%

37.98%

34.34%

37.69%

34.53%

34.24%

34.47%

45.93%

33.72%

23.31%

PAT

75.86

92.33

74.43

57.01

59.13

65.61

60.02

53.93

56.68

52.83

40.63

PAT before Minority Interest

75.86

92.33

74.43

57.01

59.13

65.61

60.02

53.93

56.68

52.83

40.63

Minority Interest

0.00

PAT Margin

16.65%

20.89%

17.45%

19.14%

16.99%

20.10%

19.17%

18.71%

16.03%

19.78%

18.57%

PAT Growth

10.44%

24.05%

30.56%

-3.59%

-9.88%

9.31%

11.29%

-4.85%

7.29%

30.03%

Unadjusted EPS

7.36

8.96

7.22

5.53

5.74

6.36

5.82

5.23

5.50

5.12

3.94

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 548.74 689.31 898.57 814.64 798.44 546.89 407.13 344.64 396.63 267.07 218.84 Net Sales Growth -38.10% -23.29% 10.30% 2.03% 46.00% 34.33% 18.13% -13.11% 48.51% 22.04% Cost Of Goods Sold 4,886.26 439.97 612.26 391.13 358.93 237.18 152.77 132.01 167.90 145.83 112.20 Gross Profit -4,337.52 249.34 286.31 423.52 439.51 309.72 254.37 212.63 228.72 121.24 106.65 GP Margin -790.45% 36.17% 31.86% 51.99% 55.05% 56.63% 62.48% 61.70% 57.67% 45.40% 48.73% Total Expenditure 448.46 566.08 740.93 617.50 595.70 391.17 303.70 273.42 285.47 195.73 160.11 Power & Fuel Cost - 5.88 4.76 5.49 5.58 4.72 4.36 2.93 2.18 1.02 0.54 % Of Sales - 0.85% 0.53% 0.67% 0.70% 0.86% 1.07% 0.85% 0.55% 0.38% 0.25% Employee Cost - 53.69 42.32 69.23 61.35 33.74 29.43 23.46 15.08 6.26 3.53 % Of Sales - 7.79% 4.71% 8.50% 7.68% 6.17% 7.23% 6.81% 3.80% 2.34% 1.61% Manufacturing Exp. - 6.30 4.95 4.88 5.39 25.65 29.98 41.44 37.17 12.66 15.88 % Of Sales - 0.91% 0.55% 0.60% 0.68% 4.69% 7.36% 12.02% 9.37% 4.74% 7.26% General & Admin Exp. - 12.99 17.05 39.48 36.36 24.68 17.07 15.16 14.63 7.36 5.21 % Of Sales - 1.88% 1.90% 4.85% 4.55% 4.51% 4.19% 4.40% 3.69% 2.76% 2.38% Selling & Distn. Exp. - 28.83 34.72 62.09 92.46 42.51 47.05 35.12 40.26 21.13 15.75 % Of Sales - 4.18% 3.86% 7.62% 11.58% 7.77% 11.56% 10.19% 10.15% 7.91% 7.20% Miscellaneous Exp. - 18.43 24.86 45.21 35.63 22.71 23.03 23.30 8.25 1.47 15.75 % Of Sales - 2.67% 2.77% 5.55% 4.46% 4.15% 5.66% 6.76% 2.08% 0.55% 3.20% EBITDA 100.28 123.23 157.64 197.14 202.74 155.72 103.43 71.22 111.16 71.34 58.73 EBITDA Margin 18.27% 17.88% 17.54% 24.20% 25.39% 28.47% 25.40% 20.67% 28.03% 26.71% 26.84% Other Income 31.90 37.12 37.63 26.54 12.51 24.35 20.29 28.00 14.07 15.75 1.87 Interest 5.68 5.41 4.41 22.80 19.69 18.61 16.41 17.98 9.72 4.03 2.15 Depreciation 14.91 12.59 8.94 21.38 20.14 13.26 11.30 10.68 6.03 3.65 5.47 PBT 98.19 142.35 181.92 179.49 175.40 148.19 96.02 70.56 109.48 79.42 52.98 Tax 28.91 33.71 55.25 56.63 62.72 48.05 34.63 29.53 49.90 26.88 12.35 Tax Rate 29.44% 26.14% 30.37% 38.98% 35.76% 32.42% 36.07% 41.85% 45.58% 33.85% 23.31% PAT 69.28 97.26 123.72 58.78 82.04 82.49 59.91 40.99 57.72 52.54 40.63 PAT before Minority Interest 66.01 95.25 126.66 88.66 112.68 100.15 61.39 41.03 59.58 52.54 40.63 Minority Interest -3.27 2.01 -2.94 -29.88 -30.64 -17.66 -1.48 -0.04 -1.86 0.00 0.00 PAT Margin 12.63% 14.11% 13.77% 7.22% 10.28% 15.08% 14.72% 11.89% 14.55% 19.67% 18.57% PAT Growth -37.16% -21.39% 110.48% -28.35% -0.55% 37.69% 46.16% -28.98% 9.86% 29.31% Unadjusted EPS 6.72 9.43 12.00 5.70 7.96 8.00 5.81 3.98 5.60 5.10 3.94

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

548.74

689.31

898.57

814.64

798.44

546.89

407.13

344.64

396.63

267.07

218.84

Net Sales Growth

-38.10%

-23.29%

10.30%

2.03%

46.00%

34.33%

18.13%

-13.11%

48.51%

22.04%

Cost Of Goods Sold

4,886.26

439.97

612.26

391.13

358.93

237.18

152.77

132.01

167.90

145.83

112.20

Gross Profit

-4,337.52

249.34

286.31

423.52

439.51

309.72

254.37

212.63

228.72

121.24

106.65

GP Margin

-790.45%

36.17%

31.86%

51.99%

55.05%

56.63%

62.48%

61.70%

57.67%

45.40%

48.73%

Total Expenditure

448.46

566.08

740.93

617.50

595.70

391.17

303.70

273.42

285.47

195.73

160.11

Power & Fuel Cost

5.88

4.76

5.49

5.58

4.72

4.36

2.93

2.18

1.02

0.54

% Of Sales

0.85%

0.53%

0.67%

0.70%

0.86%

1.07%

0.85%

0.55%

0.38%

0.25%

Employee Cost

53.69

42.32

69.23

61.35

33.74

29.43

23.46

15.08

6.26

3.53

% Of Sales

7.79%

4.71%

8.50%

7.68%

6.17%

7.23%

6.81%

3.80%

2.34%

1.61%

Manufacturing Exp.

6.30

4.95

4.88

5.39

25.65

29.98

41.44

37.17

12.66

15.88

% Of Sales

0.91%

0.55%

0.60%

0.68%

4.69%

7.36%

12.02%

9.37%

4.74%

7.26%

General & Admin Exp.

12.99

17.05

39.48

36.36

24.68

17.07

15.16

14.63

7.36

5.21

% Of Sales

1.88%

1.90%

4.85%

4.55%

4.51%

4.19%

4.40%

3.69%

2.76%

2.38%

Selling & Distn. Exp.

28.83

34.72

62.09

92.46

42.51

47.05

35.12

40.26

21.13

15.75

% Of Sales

4.18%

3.86%

7.62%

11.58%

7.77%

11.56%

10.19%

10.15%

7.91%

7.20%

Miscellaneous Exp.

18.43

24.86

45.21

35.63

22.71

23.03

23.30

8.25

1.47

15.75

% Of Sales

2.67%

2.77%

5.55%

4.46%

4.15%

5.66%

6.76%

2.08%

0.55%

3.20%

EBITDA

100.28

123.23

157.64

197.14

202.74

155.72

103.43

71.22

111.16

71.34

58.73

EBITDA Margin

18.27%

17.88%

17.54%

24.20%

25.39%

28.47%

25.40%

20.67%

28.03%

26.71%

26.84%

Other Income

31.90

37.12

37.63

26.54

12.51

24.35

20.29

28.00

14.07

15.75

1.87

Interest

5.68

5.41

4.41

22.80

19.69

18.61

16.41

17.98

9.72

4.03

2.15

Depreciation

14.91

12.59

8.94

21.38

20.14

13.26

11.30

10.68

6.03

3.65

5.47

PBT

98.19

142.35

181.92

179.49

175.40

148.19

96.02

70.56

109.48

79.42

52.98

Tax

28.91

33.71

55.25

56.63

62.72

48.05

34.63

29.53

49.90

26.88

12.35

Tax Rate

29.44%

26.14%

30.37%

38.98%

35.76%

32.42%

36.07%

41.85%

45.58%

33.85%

23.31%

PAT

69.28

97.26

123.72

58.78

82.04

82.49

59.91

40.99

57.72

52.54

40.63

PAT before Minority Interest

66.01

95.25

126.66

88.66

112.68

100.15

61.39

41.03

59.58

52.54

40.63

Minority Interest

-3.27

2.01

-2.94

-29.88

-30.64

-17.66

-1.48

-0.04

-1.86

0.00

PAT Margin

12.63%

14.11%

13.77%

7.22%

10.28%

15.08%

14.72%

11.89%

14.55%

19.67%

18.57%

PAT Growth

-37.16%

-21.39%

110.48%

-28.35%

-0.55%

37.69%

46.16%

-28.98%

9.86%

29.31%

Unadjusted EPS

6.72

9.43

12.00

5.70

7.96

8.00

5.81

3.98

5.60

5.10

3.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 682.94 603.27 541.42 491.64 432.07 368.19 314.84 258.74 210.43 166.62 Share Capital 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 Total Reserves 672.63 592.96 531.11 481.33 421.76 357.87 304.53 248.42 200.12 156.31 Non-Current Liabilities 46.59 40.60 15.73 22.84 21.78 38.76 52.44 58.78 4.66 3.86 Secured Loans 35.55 30.53 5.55 12.47 11.84 30.21 45.14 53.68 2.94 3.65 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.44 1.75 1.91 1.81 1.67 1.40 1.10 0.74 0.51 0.58 Current Liabilities 125.56 91.98 136.85 151.82 243.28 148.05 236.68 138.67 55.25 42.64 Trade Payables 58.41 30.87 35.34 63.80 35.06 50.47 58.99 92.43 40.12 31.40 Other Current Liabilities 30.34 23.47 11.81 11.84 29.10 39.13 28.52 13.82 5.33 4.35 Short Term Borrowings 35.94 36.64 82.53 61.50 49.95 28.38 23.14 18.21 2.22 3.29 Short Term Provisions 0.87 1.01 7.18 14.68 129.17 30.08 126.04 14.22 7.58 3.61 Total Liabilities 855.09 735.85 694.00 666.30 697.13 555.00 603.96 456.19 270.34 213.12 Net Block 178.86 78.32 72.48 75.34 79.09 81.50 53.53 48.79 40.03 19.93 Gross Block 202.33 93.44 83.40 80.85 122.93 119.59 86.50 77.30 64.41 40.84 Accumulated Depreciation 23.47 15.12 10.92 5.51 43.84 38.08 32.97 28.51 24.38 20.91 Non Current Assets 211.05 157.95 117.72 111.50 212.12 202.08 186.24 163.83 60.86 56.57 Capital Work in Progress 0.00 42.91 0.47 1.98 1.98 0.00 4.31 0.65 0.63 7.55 Non Current Investment 19.00 19.01 19.17 21.54 20.59 19.23 19.23 19.22 0.23 0.00 Long Term Loans & Adv. 11.95 17.38 25.31 12.23 110.45 101.35 109.18 95.17 19.97 29.09 Other Non Current Assets 1.24 0.33 0.29 0.42 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 644.05 577.90 576.29 554.80 485.02 352.49 416.30 289.94 209.49 156.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.80 0.00 Inventories 60.57 54.84 39.80 28.06 21.95 22.52 21.23 24.58 12.68 11.61 Sundry Debtors 404.91 342.09 282.54 239.41 250.58 210.61 183.53 218.21 128.59 119.61 Cash & Bank 86.62 93.29 70.29 83.57 56.90 47.37 74.12 30.82 57.90 17.98 Other Current Assets 91.95 25.28 40.38 30.37 155.59 71.99 137.41 16.33 9.51 7.35 Short Term Loans & Adv. 73.92 62.40 143.27 173.39 136.36 50.95 124.55 5.13 5.07 2.62 Net Current Assets 518.49 485.92 439.44 402.98 241.74 204.43 179.61 151.27 154.23 113.91 Total Assets 855.10 735.85 694.01 666.30 697.14 555.00 603.96 456.18 270.35 213.12

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

682.94

603.27

541.42

491.64

432.07

368.19

314.84

258.74

210.43

166.62

Share Capital

10.31

Total Reserves

672.63

592.96

531.11

481.33

421.76

357.87

304.53

248.42

200.12

156.31

Non-Current Liabilities

46.59

40.60

15.73

22.84

21.78

38.76

52.44

58.78

4.66

3.86

Secured Loans

35.55

30.53

5.55

12.47

11.84

30.21

45.14

53.68

2.94

3.65

Unsecured Loans

0.00

Long Term Provisions

2.44

1.75

1.91

1.81

1.67

1.40

1.10

0.74

0.51

0.58

Current Liabilities

125.56

91.98

136.85

151.82

243.28

148.05

236.68

138.67

55.25

42.64

Trade Payables

58.41

30.87

35.34

63.80

35.06

50.47

58.99

92.43

40.12

31.40

Other Current Liabilities

30.34

23.47

11.81

11.84

29.10

39.13

28.52

13.82

5.33

4.35

Short Term Borrowings

35.94

36.64

82.53

61.50

49.95

28.38

23.14

18.21

2.22

3.29

Short Term Provisions

0.87

1.01

7.18

14.68

129.17

30.08

126.04

14.22

7.58

3.61

Total Liabilities

855.09

735.85

694.00

666.30

697.13

555.00

603.96

456.19

270.34

213.12

Net Block

178.86

78.32

72.48

75.34

79.09

81.50

53.53

48.79

40.03

19.93

Gross Block

202.33

93.44

83.40

80.85

122.93

119.59

86.50

77.30

64.41

40.84

Accumulated Depreciation

23.47

15.12

10.92

5.51

43.84

38.08

32.97

28.51

24.38

20.91

Non Current Assets

211.05

157.95

117.72

111.50

212.12

202.08

186.24

163.83

60.86

56.57

Capital Work in Progress

0.00

42.91

0.47

1.98

0.00

4.31

0.65

0.63

7.55

Non Current Investment

19.00

19.01

19.17

21.54

20.59

19.23

19.22

0.23

0.00

Long Term Loans & Adv.

11.95

17.38

25.31

12.23

110.45

101.35

109.18

95.17

19.97

29.09

Other Non Current Assets

1.24

0.33

0.29

0.42

0.00

Current Assets

644.05

577.90

576.29

554.80

485.02

352.49

416.30

289.94

209.49

156.55

Current Investments

0.00

0.80

0.00

Inventories

60.57

54.84

39.80

28.06

21.95

22.52

21.23

24.58

12.68

11.61

Sundry Debtors

404.91

342.09

282.54

239.41

250.58

210.61

183.53

218.21

128.59

119.61

Cash & Bank

86.62

93.29

70.29

83.57

56.90

47.37

74.12

30.82

57.90

17.98

Other Current Assets

91.95

25.28

40.38

30.37

155.59

71.99

137.41

16.33

9.51

7.35

Short Term Loans & Adv.

73.92

62.40

143.27

173.39

136.36

50.95

124.55

5.13

5.07

2.62

Net Current Assets

518.49

485.92

439.44

402.98

241.74

204.43

179.61

151.27

154.23

113.91

Total Assets

855.10

735.85

694.01

666.30

697.14

555.00

603.96

456.18

270.35

213.12

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 735.61 646.00 536.24 486.62 412.62 337.08 286.88 258.01 210.66 166.62 Share Capital 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 10.31 Total Reserves 725.30 635.68 525.92 476.31 402.31 326.77 276.57 247.69 200.35 156.31 Non-Current Liabilities 46.47 37.99 12.92 32.81 49.55 67.52 95.65 96.92 39.34 3.86 Secured Loans 37.24 32.54 5.92 25.58 29.62 55.03 78.80 89.97 37.63 3.65 Unsecured Loans 0.00 0.00 0.00 0.00 8.62 2.23 8.79 1.33 0.00 0.00 Long Term Provisions 2.44 1.75 1.91 2.05 1.81 1.40 1.10 0.74 0.51 0.58 Current Liabilities 232.18 207.03 299.40 437.09 378.97 242.68 307.66 202.19 59.74 42.64 Trade Payables 94.15 78.88 58.43 98.25 108.49 80.33 82.35 118.15 40.15 31.40 Other Current Liabilities 54.63 50.24 124.46 99.93 52.76 70.30 42.12 24.45 6.10 4.35 Short Term Borrowings 66.39 64.30 105.66 187.47 62.12 61.04 57.05 45.16 5.90 3.29 Short Term Provisions 17.01 13.61 10.85 51.45 155.60 31.00 126.14 14.44 7.58 3.61 Total Liabilities 1,029.02 904.88 860.04 1,022.90 874.24 662.17 700.35 570.92 309.74 213.12 Net Block 240.97 144.97 136.48 303.86 225.25 234.38 213.31 168.23 40.03 19.93 Gross Block 276.07 169.89 157.47 326.83 300.74 293.82 262.45 205.92 64.41 40.84 Accumulated Depreciation 35.10 24.92 20.99 22.97 75.48 59.44 49.14 37.69 24.38 20.91 Non Current Assets 256.07 211.39 170.25 456.97 291.23 244.66 229.67 219.61 100.21 56.57 Capital Work in Progress 0.00 46.74 0.47 4.03 9.10 0.00 4.33 0.65 6.91 7.55 Non Current Investment 0.72 0.72 6.30 1.05 0.11 0.01 0.01 0.01 0.00 0.00 Long Term Loans & Adv. 13.15 18.63 26.72 11.45 56.77 10.27 12.02 50.72 53.28 29.09 Other Non Current Assets 1.24 0.33 0.29 136.58 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 772.95 693.49 689.79 565.93 583.00 417.08 469.26 348.89 209.54 156.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.80 0.00 Inventories 74.14 77.37 59.03 49.30 38.67 33.70 32.53 32.52 12.68 11.61 Sundry Debtors 547.91 460.73 298.48 254.45 300.93 247.47 215.03 244.64 128.59 119.61 Cash & Bank 103.32 106.63 88.86 150.50 78.18 57.29 80.37 50.35 58.01 17.98 Other Current Assets 47.58 26.21 97.11 33.24 165.22 78.62 141.34 21.37 9.46 7.35 Short Term Loans & Adv. 30.71 22.55 146.30 78.44 149.92 60.69 130.30 8.92 5.09 2.62 Net Current Assets 540.76 486.47 390.39 128.84 204.03 174.40 161.60 146.70 149.80 113.91 Total Assets 1,029.02 904.88 860.04 1,022.90 874.23 662.17 700.35 570.91 309.75 213.12

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

735.61

646.00

536.24

486.62

412.62

337.08

286.88

258.01

210.66

166.62

Share Capital

10.31

Total Reserves

725.30

635.68

525.92

476.31

402.31

326.77

276.57

247.69

200.35

156.31

Non-Current Liabilities

46.47

37.99

12.92

32.81

49.55

67.52

95.65

96.92

39.34

3.86

Secured Loans

37.24

32.54

5.92

25.58

29.62

55.03

78.80

89.97

37.63

3.65

Unsecured Loans

0.00

8.62

2.23

8.79

1.33

0.00

Long Term Provisions

2.44

1.75

1.91

2.05

1.81

1.40

1.10

0.74

0.51

0.58

Current Liabilities

232.18

207.03

299.40

437.09

378.97

242.68

307.66

202.19

59.74

42.64

Trade Payables

94.15

78.88

58.43

98.25

108.49

80.33

82.35

118.15

40.15

31.40

Other Current Liabilities

54.63

50.24

124.46

99.93

52.76

70.30

42.12

24.45

6.10

4.35

Short Term Borrowings

66.39

64.30

105.66

187.47

62.12

61.04

57.05

45.16

5.90

3.29

Short Term Provisions

17.01

13.61

10.85

51.45

155.60

31.00

126.14

14.44

7.58

3.61

Total Liabilities

1,029.02

904.88

860.04

1,022.90

874.24

662.17

700.35

570.92

309.74

213.12

Net Block

240.97

144.97

136.48

303.86

225.25

234.38

213.31

168.23

40.03

19.93

Gross Block

276.07

169.89

157.47

326.83

300.74

293.82

262.45

205.92

64.41

40.84

Accumulated Depreciation

35.10

24.92

20.99

22.97

75.48

59.44

49.14

37.69

24.38

20.91

Non Current Assets

256.07

211.39

170.25

456.97

291.23

244.66

229.67

219.61

100.21

56.57

Capital Work in Progress

0.00

46.74

0.47

4.03

9.10

0.00

4.33

0.65

6.91

7.55

Non Current Investment

0.72

6.30

1.05

0.11

0.01

0.00

Long Term Loans & Adv.

13.15

18.63

26.72

11.45

56.77

10.27

12.02

50.72

53.28

29.09

Other Non Current Assets

1.24

0.33

0.29

136.58

0.00

Current Assets

772.95

693.49

689.79

565.93

583.00

417.08

469.26

348.89

209.54

156.55

Current Investments

0.00

0.80

0.00

Inventories

74.14

77.37

59.03

49.30

38.67

33.70

32.53

32.52

12.68

11.61

Sundry Debtors

547.91

460.73

298.48

254.45

300.93

247.47

215.03

244.64

128.59

119.61

Cash & Bank

103.32

106.63

88.86

150.50

78.18

57.29

80.37

50.35

58.01

17.98

Other Current Assets

47.58

26.21

97.11

33.24

165.22

78.62

141.34

21.37

9.46

7.35

Short Term Loans & Adv.

30.71

22.55

146.30

78.44

149.92

60.69

130.30

8.92

5.09

2.62

Net Current Assets

540.76

486.47

390.39

128.84

204.03

174.40

161.60

146.70

149.80

113.91

Total Assets

1,029.02

904.88

860.04

1,022.90

874.23

662.17

700.35

570.91

309.75

213.12

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 58.03 48.29 22.67 38.48 59.61 15.35 64.71 -51.86 68.74 23.66 PBT 121.71 120.01 86.84 94.91 100.21 91.25 82.30 104.83 79.71 52.98 Adjustment 1.20 3.36 0.77 28.12 7.21 14.91 6.89 5.09 4.76 6.51 Changes in Working Capital -33.02 -25.53 -29.06 -47.37 -27.78 -50.62 8.78 -123.38 -4.84 -21.63 Cash after chg. in Working capital 89.89 97.84 58.54 75.65 79.64 55.55 97.97 -13.45 79.63 37.87 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -31.86 -49.55 -35.87 -37.17 -20.03 -40.19 -33.26 -38.41 -10.89 -14.21 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -57.89 -68.04 16.36 -29.34 -10.29 -21.49 -24.00 -26.80 -15.87 -9.79 Net Fixed Assets -65.98 -52.48 -1.04 42.08 -5.32 -28.78 -12.86 -12.91 -16.65 -9.20 Net Investments 0.01 0.16 2.37 -0.95 -1.36 0.00 -0.01 -18.19 -1.03 0.00 Others 8.08 -15.72 15.03 -70.47 -3.61 7.29 -11.13 4.30 1.81 -0.59 Cash from Financing Activity -2.86 9.05 -21.91 -14.77 -35.34 -31.23 -49.97 51.56 -12.95 -11.20 Net Cash Inflow / Outflow -2.72 -10.70 17.12 -5.63 13.98 -37.37 -9.26 -27.09 39.92 2.66 Opening Cash & Equivalents 13.75 24.45 7.33 12.95 3.40 38.70 52.58 57.90 17.98 15.32 Closing Cash & Equivalent 11.03 13.75 24.45 7.33 12.95 3.40 43.32 30.82 57.90 17.98

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

58.03

48.29

22.67

38.48

59.61

15.35

64.71

-51.86

68.74

23.66

PBT

121.71

120.01

86.84

94.91

100.21

91.25

82.30

104.83

79.71

52.98

Adjustment

1.20

3.36

0.77

28.12

7.21

14.91

6.89

5.09

4.76

6.51

Changes in Working Capital

-33.02

-25.53

-29.06

-47.37

-27.78

-50.62

8.78

-123.38

-4.84

-21.63

Cash after chg. in Working capital

89.89

97.84

58.54

75.65

79.64

55.55

97.97

-13.45

79.63

37.87

Interest Paid

0.00

Tax Paid

-31.86

-49.55

-35.87

-37.17

-20.03

-40.19

-33.26

-38.41

-10.89

-14.21

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-57.89

-68.04

16.36

-29.34

-10.29

-21.49

-24.00

-26.80

-15.87

-9.79

Net Fixed Assets

-65.98

-52.48

-1.04

42.08

-5.32

-28.78

-12.86

-12.91

-16.65

-9.20

Net Investments

0.01

0.16

2.37

-0.95

-1.36

0.00

-0.01

-18.19

-1.03

0.00

Others

8.08

-15.72

15.03

-70.47

-3.61

7.29

-11.13

4.30

1.81

-0.59

Cash from Financing Activity

-2.86

9.05

-21.91

-14.77

-35.34

-31.23

-49.97

51.56

-12.95

-11.20

Net Cash Inflow / Outflow

-2.72

-10.70

17.12

-5.63

13.98

-37.37

-9.26

-27.09

39.92

2.66

Opening Cash & Equivalents

13.75

24.45

7.33

12.95

3.40

38.70

52.58

57.90

17.98

15.32

Closing Cash & Equivalent

11.03

13.75

24.45

7.33

12.95

3.40

43.32

30.82

57.90

17.98

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 45.28 39.95 17.64 289.47 112.95 48.94 41.15 6.50 35.46 0.00 PBT 128.97 181.91 179.49 175.40 148.19 96.02 70.56 109.48 79.42 0.00 Adjustment 24.37 -10.97 17.55 36.24 18.18 22.48 24.11 9.71 4.76 0.00 Changes in Working Capital -69.22 -183.07 -140.80 113.48 -8.33 -60.94 -19.30 -73.94 -37.83 0.00 Cash after chg. in Working capital 84.12 -12.13 56.24 325.13 158.05 57.56 75.36 45.25 46.35 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -38.84 52.08 -38.61 -35.66 -45.10 -8.63 -34.21 -38.75 -10.89 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -48.95 -73.52 50.24 -231.25 -49.84 -38.98 -10.90 -124.05 -21.91 0.00 Net Fixed Assets -65.98 -52.48 -1.04 42.08 -5.32 -28.78 -12.86 -12.91 -16.65 Net Investments 0.01 0.16 2.37 -0.95 -1.36 0.00 -0.01 -18.19 -1.03 Others 17.02 -21.20 48.91 -272.38 -43.16 -10.20 1.97 -92.95 -4.23 Cash from Financing Activity -3.83 16.83 -75.98 -10.13 -40.25 -43.26 -8.47 109.89 26.48 0.00 Net Cash Inflow / Outflow -7.50 -16.74 -8.10 48.09 22.85 -33.31 21.77 -7.66 40.02 0.00 Opening Cash & Equivalents 15.04 36.95 47.41 0.00 5.09 49.57 27.79 58.01 17.98 0.00 Closing Cash & Equivalent 15.34 15.04 36.95 47.41 27.60 16.26 49.57 50.35 58.01 0.00

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

45.28

39.95

17.64

289.47

112.95

48.94

41.15

6.50

35.46

0.00

PBT

128.97

181.91

179.49

175.40

148.19

96.02

70.56

109.48

79.42

0.00

Adjustment

24.37

-10.97

17.55

36.24

18.18

22.48

24.11

9.71

4.76

0.00

Changes in Working Capital

-69.22

-183.07

-140.80

113.48

-8.33

-60.94

-19.30

-73.94

-37.83

0.00

Cash after chg. in Working capital

84.12

-12.13

56.24

325.13

158.05

57.56

75.36

45.25

46.35

0.00

Interest Paid

0.00

Tax Paid

-38.84

52.08

-38.61

-35.66

-45.10

-8.63

-34.21

-38.75

-10.89

0.00

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-48.95

-73.52

50.24

-231.25

-49.84

-38.98

-10.90

-124.05

-21.91

0.00

Net Fixed Assets

-65.98

-52.48

-1.04

42.08

-5.32

-28.78

-12.86

-12.91

-16.65

Net Investments

0.01

0.16

2.37

-0.95

-1.36

0.00

-0.01

-18.19

-1.03

Others

17.02

-21.20

48.91

-272.38

-43.16

-10.20

1.97

-92.95

-4.23

Cash from Financing Activity

-3.83

16.83

-75.98

-10.13

-40.25

-43.26

-8.47

109.89

26.48

0.00

Net Cash Inflow / Outflow

-7.50

-16.74

-8.10

48.09

22.85

-33.31

21.77

-7.66

40.02

0.00

Opening Cash & Equivalents

15.04

36.95

47.41

0.00

5.09

49.57

27.79

58.01

17.98

0.00

Closing Cash & Equivalent

15.34

15.04

36.95

47.41

27.60

16.26

49.57

50.35

58.01

0.00

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 66.21 58.49 52.49 47.66 41.89 35.65 30.39 24.85 20.40 16.15 ROA 11.61% 10.41% 8.38% 8.67% 10.48% 10.36% 10.17% 15.60% 21.85% 21.85% ROE 14.36% 13.00% 11.04% 12.80% 16.41% 17.62% 18.93% 24.29% 28.02% 27.10% ROCE 17.46% 18.80% 15.60% 19.25% 23.43% 23.91% 25.07% 40.59% 42.78% 34.92% Fixed Asset Turnover 2.99 4.82 3.63 3.44 2.70 3.06 3.53 5.00 5.09 5.72 Receivable days 308.46 267.22 319.34 255.29 257.00 228.48 253.33 178.64 169.17 158.14 Inventory Days 47.66 40.49 41.51 26.05 24.78 25.36 28.89 19.20 16.56 35.19 Payable days 50.35 39.16 90.96 75.73 75.81 99.92 138.16 97.63 67.62 46.59 Cash Conversion Cycle 305.78 268.56 269.89 205.62 205.97 153.91 144.06 100.20 118.11 146.74 Total Debt/Equity 0.13 0.12 0.17 0.15 0.19 0.24 0.28 0.30 0.03 0.05 Interest Cover 27.71 39.08 13.49 11.46 8.41 9.14 9.72 16.99 20.81 25.67

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

66.21

58.49

52.49

47.66

41.89

35.65

30.39

24.85

20.40

16.15

ROA

11.61%

10.41%

8.38%

8.67%

10.48%

10.36%

10.17%

15.60%

21.85%

ROE

14.36%

13.00%

11.04%

12.80%

16.41%

17.62%

18.93%

24.29%

28.02%

27.10%

ROCE

17.46%

18.80%

15.60%

19.25%

23.43%

23.91%

25.07%

40.59%

42.78%

34.92%

Fixed Asset Turnover

2.99

4.82

3.63

3.44

2.70

3.06

3.53

5.00

5.09

5.72

Receivable days

308.46

267.22

319.34

255.29

257.00

228.48

253.33

178.64

169.17

158.14

Inventory Days

47.66

40.49

41.51

26.05

24.78

25.36

28.89

19.20

16.56

35.19

Payable days

50.35

39.16

90.96

75.73

75.81

99.92

138.16

97.63

67.62

46.59

Cash Conversion Cycle

305.78

268.56

269.89

205.62

205.97

153.91

144.06

100.20

118.11

146.74

Total Debt/Equity

0.13

0.12

0.17

0.15

0.19

0.24

0.28

0.30

0.03

0.05

Interest Cover

27.71

39.08

13.49

11.46

8.41

9.14

9.72

16.99

20.81

25.67

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 71.32 62.63 51.99 47.18 40.00 32.64 27.67 24.78 20.42 16.15 ROA 9.85% 14.35% 9.42% 11.88% 13.04% 9.01% 6.46% 13.53% 20.09% 19.06% ROE 13.79% 21.43% 17.34% 25.06% 26.73% 19.74% 15.17% 25.56% 27.85% 24.38% ROCE 16.75% 26.58% 24.61% 31.06% 32.07% 23.57% 20.56% 36.18% 38.76% 31.53% Fixed Asset Turnover 3.09 5.49 3.37 2.56 1.85 1.47 1.48 2.95 5.09 5.37 Receivable days 267.05 154.20 123.80 126.33 182.13 206.07 241.81 171.03 169.17 199.09 Inventory Days 40.11 27.70 24.25 20.01 24.04 29.51 34.22 20.71 16.56 19.33 Payable days 58.13 35.01 51.74 67.63 95.25 108.77 148.76 105.12 67.61 73.84 Cash Conversion Cycle 249.03 146.89 96.31 78.70 110.92 126.81 127.26 86.63 118.11 144.57 Total Debt/Equity 0.16 0.16 0.22 0.46 0.32 0.47 0.60 0.58 0.21 0.05 Interest Cover 24.84 42.21 7.37 9.91 8.96 6.85 4.92 12.27 20.70 25.67

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

71.32

62.63

51.99

47.18

40.00

32.64

27.67

24.78

20.42

16.15

ROA

9.85%

14.35%

9.42%

11.88%

13.04%

9.01%

6.46%

13.53%

20.09%

19.06%

ROE

13.79%

21.43%

17.34%

25.06%

26.73%

19.74%

15.17%

25.56%

27.85%

24.38%

ROCE

16.75%

26.58%

24.61%

31.06%

32.07%

23.57%

20.56%

36.18%

38.76%

31.53%

Fixed Asset Turnover

3.09

5.49

3.37

2.56

1.85

1.47

1.48

2.95

5.09

5.37

Receivable days

267.05

154.20

123.80

126.33

182.13

206.07

241.81

171.03

169.17

199.09

Inventory Days

40.11

27.70

24.25

20.01

24.04

29.51

34.22

20.71

16.56

19.33

Payable days

58.13

35.01

51.74

67.63

95.25

108.77

148.76

105.12

67.61

73.84

Cash Conversion Cycle

249.03

146.89

96.31

78.70

110.92

126.81

127.26

86.63

118.11

144.57

Total Debt/Equity

0.16

0.22

0.46

0.32

0.47

0.60

0.58

0.21

0.05

Interest Cover

24.84

42.21

7.37

9.91

8.96

6.85

4.92

12.27

20.70

25.67

Bliss GVS Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506197 | NSE: BLISSGVS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update

Bliss GVS Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 506197 | NSE: BLISSGVS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update